Brief report · 29 Dec 2025
Conference abstractPublished 2 Jul 2012
A novel approach to prevent the deregulation of a neuronal kinase involved in neurodegenerative diseases
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The Biology of Neurodegeneration program evolved from our laboratory studying the basic biology of neuronal cytoskeletal protein phosphorylation during development and normal function in the adult. To understand the molecular basis of neurodegeneration our major focus has been to study the regulation of compartment-specific patterns of cytoskeletal protein phosphorylation in neuronal perikarya and axons. We have demonstrated that phosphorylation of the numerous acceptor sites on such proteins as Tau and neurofilament was tightly regulated topographically and generally confined to the axonal compartment. We identified cyclin dependent kinase5 (Cdk5); a neuron specific kinase is the major kinase involved in the phosphorylation of these cytoskeletal proteins in the nervous system. It was recognized that in neurodegenerative disorders such as Alzheimer?s disease (AD) and Amyotrophic lateral sclerosis (ALS), the pathology was characterized by hyper activation of Cdk5 and accumulation of aberrantly hyper phosphorylated cytoskeletal proteins in cell bodies, suggesting that topographic regulation had been compromised. This led inevitably into studies of neurodegeneration in cell culture and model mice with emphasis on Cdk5, that targets numerous neuronal proteins including cytoskeletal protein regulation by phosphorylation, which when deregulated, is responsible for the pathology seen in neurodegenerative diseases. In cell systems, neuronal stress leads to deregulated kinases, for example, Cdk5, accompanied by abnormal cytoskeletal protein phosphorylation and cell death characteristic of neurodegeneration. Recently we have developed peptides derived from, p35, and a neuron specific activator of Cdk5, for deregulated Cdk5 activity which rescue cells in vitro from stress induced pathology. The questions currently being investigated are (1) How is cytoskeletal protein phosphorylation topographically regulated in neurons? (2) What factors are responsible for the deregulation of Cdk5 in neurons? (3) Can mouse models of AD and ALS be treated therapeutically with peptides that specifically inhibit deregulated Cdk5?
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Molecular Biomarkers & Diagnosis.
Commentary · 29 Dec 2025
Molecular Diagnostics: Revolutionizing Precision Healthcare
Commentary · 29 Dec 2025
Genomic Biomarkers Revolutionizing Disease Diagnosis and Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Biomarkers & Diagnosis
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Harish C. Pant”
